Stanford University
Showing 6,421-6,430 of 34,981 Results
-
Quinn Daedal
Academic Technology Specialist in Literatures, Cultures, and Languages, Center for Interdisciplinary Digital Research
BioQuinn Daedal (they/them) is the Academic Technology Specialist in the Division of Literatures, Cultures, and Languages, and in the Library, at Stanford University. Prior to coming to Stanford in 2018, Quinn’s many DH adventures included supporting the high-performance computing cluster at UC Berkeley, running the DiRT tool directory with support from the Mellon Foundation, writing books on Drupal for Humanists and University of Chicago library graffiti, and working on the program staff of Project Bamboo, a failed digital humanities cyberinfrastructure initiative.
Quinn has a BA/MA in Slavic Linguistics from the University of Chicago, and an MLIS from the University of Illinois at Urbana-Champaign. Since coming to Stanford, Quinn has supported numerous non-English DH projects, taught courses on non-English DH, started a Textile Makerspace and YarnLab, developed a tabletop roleplaying game to teach DH project management, and started the Data-Sitters Club, a feminist DH pedagogy and research group focused on Ann M. Martin’s 90’s girls series “The Baby-Sitters Club”. Quinn has served as co-President of the Association for Computers and the Humanities (the US scholarly association for digital humanities) and its representative to ADHO, and advocates for better support for DH in languages other than English. -
Saurabh Dahiya, MD, FACP
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Saurabh Dahiya is a cancer specialist board-certified in internal medicine, hematology, and medical oncology. He serves as Associate Professor of Medicine at Stanford University School of Medicine and Clinical Director of Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy, where he provides patient-centered care for individuals with cancer.
Dr. Dahiya’s research focuses on advancing cellular immunotherapies for hematologic malignancies, including CAR T-cell platforms and next-generation multiantigen targeting strategies for lymphoma. His work aims to address high tumor bulk disease and develop novel cell therapy approaches that enhance durability and response in hematologic cancers. He leads multiple investigator-initiated and industry-sponsored trials in cellular immunotherapy with a focus on translating correlative research insights into improved patient outcomes.
He has authored more than 100 peer-reviewed publications in journals such as The New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Blood, and Blood Advances. Dr. Dahiya serves as Hematology Lead Editor for Critical Reviews in Oncology and Hematology and is an active member of ASH, ASTCT, and ASCO. Before joining Stanford, he was on faculty at the University of Maryland’s Greenebaum Comprehensive Cancer Center, where he helped develop the Cellular Immunotherapy Program.
